Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.91 USD | -1.03% | +2.18% | -13.81% |
May. 23 | Cantor Fitzgerald Adjusts Alkermes Price Target to $48 From $43, Maintains Overweight Rating | MT |
May. 02 | UBS Adjusts Price Target on Alkermes to $21 From $23, Maintains Sell Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.81% | 4.05B | |
+51.85% | 57.87B | |
+41.14% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Transcript : Alkermes plc Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 11